This is a multi-centre study conducted in four countries. A total of 60 subjects with Alzheimer's disease who are on standard-of-care will be enrolled to receive one of 3 active HTL0018318 or placebo for a period of four weeks
Multi-centre study of HTL0018318 in patients with Alzheimer's disease as an add-on to standard-of-care